QC

Governor in Council selection processes open for the Employment Insurance Board of Appeal

Retrieved on: 
Thursday, May 9, 2024

GATINEAU, QC, May 9, 2024 /CNW/ - Today, Minister of Employment, Workforce Development and Official Languages Randy Boissonnault announced that the Governor in Council has launched selection processes to identify a diverse group of qualified Canadians to join the new Employment Insurance Board of Appeal as Governor in Council appointees.

Key Points: 
  • GATINEAU, QC, May 9, 2024 /CNW/ - Today, Minister of Employment, Workforce Development and Official Languages Randy Boissonnault announced that the Governor in Council has launched selection processes to identify a diverse group of qualified Canadians to join the new Employment Insurance Board of Appeal as Governor in Council appointees.
  • Once established, the Employment Insurance Board of Appeal will assume responsibility from the Social Security Tribunal for hearing and deciding first-level appeals under the Employment Insurance Act.
  • Under the new Employment Insurance Board of Appeal, first-level Employment Insurance appeals will be considered by three-member panels composed of representatives of the government, workers and employers equally.
  • 1 in March 2023, to enable the creation of the Employment Insurance Board of Appeal, received royal assent and became law on June 22, 2023.

Government of Canada launches new call for proposals to increase the production of alternate format materials for persons with print disabilities

Retrieved on: 
Thursday, May 9, 2024

About half (2.5 million people) indicated they require reading materials in an alternate format, such as large print, Braille, accessible electronic or audio files, to be able to read.

Key Points: 
  • About half (2.5 million people) indicated they require reading materials in an alternate format, such as large print, Braille, accessible electronic or audio files, to be able to read.
  • Access to alternate format reading materials for educational, professional and personal purposes, is critical to ensuring the full participation of persons with print disabilities in society.
  • Through the Equitable Access to Reading Program, we are taking concrete steps to increase access to alternate reading format materials.
  • Since 2005, the Government of Canada has provided approximately $48 million to support the production and distribution of alternate format reading materials.

Converge Reports First Quarter 2024 Results

Retrieved on: 
Thursday, May 9, 2024

TORONTO, and GATINEAU, QC, May 9, 2024 /PRNewswire/ - Converge Technology Solutions Corp. ("Converge" or "the Company") (TSX:CTS) (FSE:0ZB) (OTCQX:CTSDF) is pleased to provide its financial results for the three month period ended March 31, 2024.

Key Points: 
  • TORONTO, and GATINEAU, QC, May 9, 2024 /PRNewswire/ - Converge Technology Solutions Corp. ("Converge" or "the Company") (TSX:CTS) (FSE:0ZB) (OTCQX:CTSDF) is pleased to provide its financial results for the three month period ended March 31, 2024.
  • All figures are in Canadian dollars unless otherwise stated.
  • "With our 3rd consecutive quarter of Billion-dollar sales and strong cash generation, we continue to demonstrate our position as a leading IT Service Provider," said Shaun Maine, Group CEO.
  • "Our Advise, Implement and Manage go-to-market strategy continues to drive our cross-sell efforts towards higher margin solutions and offerings across our key practice areas, demonstrated by our strong software sales during the quarter.

Converge Reports First Quarter 2024 Results

Retrieved on: 
Thursday, May 9, 2024

TORONTO, and GATINEAU, QC, May 9, 2024 /PRNewswire/ -- Converge Technology Solutions Corp. ("Converge" or "the Company") (TSX:CTS) (FSE:0ZB) (OTCQX:CTSDF) is pleased to provide its financial results for the three month period ended March 31, 2024. All figures are in Canadian dollars unless otherwise stated.

Key Points: 
  • TORONTO, and GATINEAU, QC, May 9, 2024 /PRNewswire/ -- Converge Technology Solutions Corp. ("Converge" or "the Company") (TSX:CTS) (FSE:0ZB) (OTCQX:CTSDF) is pleased to provide its financial results for the three month period ended March 31, 2024.
  • All figures are in Canadian dollars unless otherwise stated.
  • "With our 3rd consecutive quarter of Billion-dollar sales and strong cash generation, we continue to demonstrate our position as a leading IT Service Provider," said Shaun Maine, Group CEO.
  • "Our Advise, Implement and Manage go-to-market strategy continues to drive our cross-sell efforts towards higher margin solutions and offerings across our key practice areas, demonstrated by our strong software sales during the quarter.

Teknova Launches Proprietary Build-Tek™ Solutions Custom Configurator and Latest AAV-Tek™ Product to Further Accelerate Novel Therapy Development

Retrieved on: 
Tuesday, May 7, 2024

HOLLISTER, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today launched the Company’s first custom product configurator, Build-TekTM Solutions, specifically created to address the need for fast turnaround, high-quality buffers for use during early-stage therapy development. Teknova also announced the availability of the latest product in their proprietary AAV-TekTM Solutions product line – the AAV-Tek AAV Stabilizer – that substantially improves recovery and protects capsid integrity across the purification workflow.

Key Points: 
  • Teknova also announced the availability of the latest product in their proprietary AAV-TekTM Solutions product line – the AAV-Tek AAV Stabilizer – that substantially improves recovery and protects capsid integrity across the purification workflow.
  • Our custom configurator is easy to use, and by leveraging our modular manufacturing platform, products ship in a matter of days.
  • “We’re also expanding our support for gene therapy developers with the latest offering in our AAV-Tek Solutions proprietary product line, the AAV-Tek AAV Stabilizer,” continued Mr. Gunstream.
  • For more information about the Build-Tek Solutions Custom Configurator or to place an order, click here .

Successful FDA Inspection at Dipharma Facility in Kalamazoo, MI, USA

Retrieved on: 
Tuesday, May 7, 2024

At the closing meeting the inspectors congratulated the Dipharma team members on the Current Good Manufacturing Practices (CGMP) Systems they created and their overall commitment to quality.

Key Points: 
  • At the closing meeting the inspectors congratulated the Dipharma team members on the Current Good Manufacturing Practices (CGMP) Systems they created and their overall commitment to quality.
  • "The successful closure of the FDA's Pre-Approval Inspection (PAI) marks a significant achievement for our US facility, Dipharma Inc. Congratulations to the whole team for this great accomplishment," stated Jorge Nogueira, Chief Executive Officer of Dipharma Francis.
  • "This inspection, the first conducted by the FDA at our US facility, underscores the Dipharma Group's unwavering commitment to continuously improve our GMP Systems and uphold the highest quality standards.
  • Dipharma Inc.’s Kalamazoo facility provides world-class CDMO services and API supplies for the Group’s pre-clinical and clinical customers.

Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts

Retrieved on: 
Monday, May 6, 2024

MARLBOROUGH, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company®, has opened its Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts to meet the accelerating demand for its spatial biology solutions and the increased utilization of the company’s PhenoCycler®-Fusion and the PhenoImager® HT platforms.

Key Points: 
  • MARLBOROUGH, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company®, has opened its Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts to meet the accelerating demand for its spatial biology solutions and the increased utilization of the company’s PhenoCycler®-Fusion and the PhenoImager® HT platforms.
  • “Spatial biology is transforming drug discovery, translational sciences, and clinical research, and advancing our ability to understand biology, disease progression, and patients’ response to therapy,” said Brian McKelligon, CEO of Akoya Biosciences.
  • Co-location of these functional areas enables a more rapid response to growing demand, simplifies manufacturing and supply chains, and facilitates gross margin improvement initiatives.
  • Now fully operational, the primary focus will be the manufacturing and QC of Akoya’s molecular barcoded antibodies and accompanying reagents.

Commission for Environmental Cooperation to Convene North American Environmental Leaders for #CEC31, to Be Held 24-26 June in Wilmington, North Carolina, USA

Retrieved on: 
Wednesday, May 8, 2024

2024 also marks the CEC's 30th anniversary, presenting an opportunity for the CEC and North America to reflect upon and showcase three decades of regional environmental cooperation.

Key Points: 
  • 2024 also marks the CEC's 30th anniversary, presenting an opportunity for the CEC and North America to reflect upon and showcase three decades of regional environmental cooperation.
  • Day three will conclude with the Council Public Session, which presents an opportunity for North Americans to engage with the top environmental officials in the region.
  • Each year, the CEC convenes the top environmental leaders from Canada, Mexico and the United States to engage with the public in a dialogue on pressing environmental issues facing North America.
  • Open Dialogue on Opportunities for Environmental Trilateral Cooperation: Can We Think about Environmental Justice From a Regional North American Perspective?

Unifor denounces Rayonier's abandonment of Témiscaming and lack of response from Quebec government

Retrieved on: 
Wednesday, May 8, 2024

Unifor strongly condemns RYAM's statement, describing the move as "totally devoid of any human consideration."

Key Points: 
  • Unifor strongly condemns RYAM's statement, describing the move as "totally devoid of any human consideration."
  • Daniel Cloutier, Unifor Quebec Director, unequivocally stated: "What we're seeing here is a company that's sacrificing the well-being of an entire community to prove its profitability to third parties.
  • Unifor is calling on RYAM to reconsider its decision and to maintain the integrity of the Témiscaming plant, an exceptional industrial site.
  • It is also adamant in its demand that the provincial government intervene immediately to save the jobs and communities affected by this crisis.

Minister St-Onge announces the appointment of Sylvain Lafrance as Chairperson of Telefilm Canada

Retrieved on: 
Wednesday, May 8, 2024

Sylvain Lafrance, a communications and media management expert, becomes Telefilm Canada's Chairperson for a five-year term

Key Points: 
  • Sylvain Lafrance, a communications and media management expert, becomes Telefilm Canada's Chairperson for a five-year term
    GATINEAU, QC, May 8, 2024 /CNW/ - Today, the Honourable Pascale St-Onge, Minister of Canadian Heritage, announced the appointment of Sylvain Lafrance as Chairperson of Telefilm Canada.
  • With a career spanning more than three decades at CBC/Radio-Canada, Sylvain Lafrance has made his mark as an expert in the fields of media management and communications.
  • Under his leadership, Telefilm Canada rose to the many challenges presented by the pandemic, for which we are grateful."
  • Under the Telefilm Canada Act, the chairperson is appointed by the Governor in Council.